Paclitaxel naprod export data is a consolidated report based on bills of lading, shipping bills & invoices filed at Indian customs, ports while Paclitaxel naprod export from India.
Date | Indian Port | CTH | Item Description | Quantity | UQC | U.P.USD | FOB USD | Destination Port | Country |
---|---|---|---|---|---|---|---|---|---|
12-Oct-2016 | bombay air cargo | 30049044 | paclitaxel naprod 30 mg / 5 ml | 50 | VLS | 18.13 | 906.69 | riga | latvia |
01-Apr-2016 | bombay air cargo | 30049044 | paclitaxel naprod inj. 100 mg / 16.67 ml | 3000 | VLS | 52.13 | 156395.64 | tashkent | uzbekistan |
07-Feb-2016 | bombay air cargo | 30049044 | paclitaxel naprod 260mg/43.34 ml | 112 | VLS | 86.11 | 9644.42 | tashkent | uzbekistan |
07-Feb-2016 | bombay air cargo | 30049044 | paclitaxel naprod 260mg/43.34 ml | 4388 | VLS | 86.11 | 377854.51 | tashkent | uzbekistan |
26-Jan-2016 | bombay air cargo | 30049044 | paclitaxel naprod 30 mg / 5 ml | 1 | VLS | 0.10 | 0.10 | ashkhabad | turkmenistan |
26-Jan-2016 | bombay air cargo | 30049044 | paclitaxel naprod inj. 100 mg / 16.67 ml | 1 | VLS | 0.10 | 0.10 | ashkhabad | turkmenistan |
26-Jan-2016 | bombay air cargo | 30049044 | paclitaxel naprod inj. 260 mg / 43.34 ml | 1 | VLS | 0.10 | 0.10 | ashkhabad | turkmenistan |
03-Jan-2016 | bombay air cargo | 30049044 | paclitaxel naprod inj. 100 mg / 16.67 ml | 149 | VLS | 29.58 | 4406.89 | riga | latvia |
03-Jan-2016 | bombay air cargo | 30049044 | paclitaxel naprod inj. 260 mg / 43.34 ml | 149 | VLS | 69.01 | 10282.76 | riga | latvia |
Seair Exim Solutions provides complete details of Paclitaxel naprod exports from India. Paclitaxel naprod export data is collected from Indian customs with shipment details like exporter name, Indian export port name, price, HS code, etc. Paclitaxel naprod export Data of India helps you to find the answers of the following questions easily
We have successfully served many reputable clients for Import-Export Data Information Services. Here are some of our clients:
Copyright © 2009 - 2024 www.seair.co.in. All Rights Reserved.